Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
- 21-Nov-24
Select bar for recommendation details.
Recommendations | 21-Nov-24 | |
---|---|---|
Buy | 2 | |
Outperform | 6 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 8 analysts offering 12 month price targets for Aquestive Therapeutics Inc have a median target of 10.00, with a high estimate of 15.00 and a low estimate of 5.50. The median estimate represents a 121.73% increase from the last price of 4.51.
High | 232.6% | 15.00 |
Med | 121.7% | 10.00 |
Low | 22.0% | 5.50 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 03, 2025.
Average growth rate | -148.16% |
Average growth rate | +39.97% |
More ▼
Revenue history & estimates in USD
Average growth rate | +6.73% |
Average growth rate | -4.08% |
More ▼